Navigation Links
Optimal dose of vitamin E maximizes benefits, minimizes risk
Date:10/30/2008

Corvallis, Oregon October 29, 2008 -- Vitamin E has been heralded for its ability to reduce the risk of blood clots, heart attack, and sudden death. Yet in some people, vitamin E causes bleeding. Scientists have known for more than 50 years that excess vitamin E promotes bleeding by interfering with vitamin K, which is essential in blood clotting. However, they haven't been able to pinpoint how the two vitamins interact. Nutrition researcher Maret Traber of Oregon State University reviews studies of possible explanations of the interaction in an article published recently in Nutrition Reviews.

One of the most compelling studies of the benefits of vitamin E is the Women's Health Study, in which 40,000 healthy women, 45 and older, took 600 IU vitamin E supplements or a placebo every other day for 10 years. Women taking the supplements had 24 percent fewer deaths from heart disease. Vitamin E's protective effect appeared even stronger in women 65 and older. Those taking the vitamin experienced a 26 percent reduction in cardiovascular events and a 49 percent reduction in cardiovascular deaths.

"That's a significant benefit," Traber said. Yet, she added, "In some people high doses of vitamin E increase the tendency to bleed. Women enrolled in the study had an increase in nose bleeds."

To lessen the bleeding risk, the U.S.-based Food and Nutrition Board in 2000 set the upper tolerable limit for daily vitamin E intake at 1500 I.U.

Research Traber reviewed suggests that a shared metabolic pathway in the liver causes vitamins E and K to interact. Vitamin K in the liver appears to diminish as vitamin E increases.

"Several different explanations could account for the interaction between the two vitamins," Traber said. "We need more research to understand the delicate balance between vitamins E and K."


'/>"/>

Contact: Amy Molnar
journalnews@bos.blackwellpublishing.net
201-748-8844
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related biology news :

1. Genetics determine optimal drug dose of common anticoagulant
2. Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
3. Lack of vitamin D linked to Parkinsons disease
4. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
5. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
6. Dont forget the vitamin A when working with its carrier protein
7. Variant of vitamin D receptor gene linked to melanoma risk
8. Majority of osteoporosis patients not receiving calcium and vitamin D with treatment
9. Vitamin A pushes breast cancer to form blood vessel cells
10. Researchers identify cancer preventive properties in common vitamin supplement
11. Newborn vitamin A reduces infant mortality

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...2009 Childhood obesity in the United States is re...urth of advertising on daytime and prime time tele...ng questions about the role television plays in ob...he Journal of Nutrition Education and Behavior e...ht be a large contributor to the problem. , Rese...
(Date:11/4/2009)...at deciphered the DNA codes, or genomes, of the fa...oined The Genome 10K Project, an international eff...nces on 10,000 species of animals for conducting c...ot be achieved. , Participating in The Genome 10...ov. 5, 2009 issue of the Journal of Heredity , ar...
(Date:11/4/2009)... Oct. 19 Spectros, developer and m...ing devices which shed light on life-threatening d...ive distribution deals for both its T-Stat® V...ed include Australia, New Zealand, The Netherland... France, Spain, Portugal, Poland, Greece, Turkey, ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Singapore scientists join international study of 10,000 vertebrates' genomes 2Spectros Signs New International Distribution Deals 2Mayo Clinic researchers lead national trial testing new treatment for chronic severe indigestion 57531 1Mayo Clinic researchers lead national trial testing new treatment for chronic severe indigestion 57531 2Mayo Clinic researchers lead national trial testing new treatment for chronic severe indigestion 57531 3Proposal to reintroduce Iberian lynx on abandoned agricultural land 57527 1Proposal to reintroduce Iberian lynx on abandoned agricultural land 57527 2National new biology initiative offers potential for remarkable and far reaching benefits 9968 1National new biology initiative offers potential for remarkable and far reaching benefits 9968 2National new biology initiative offers potential for remarkable and far reaching benefits 9968 3
...ble in Spanish . , The research reveals that a...comes accustomed to the presence of an exogenous s...dependence on an external source--in this case, al...p "Alcoholism and drug addiction" , of the Unive...reasons to become alcoholic, many social, family, ...
...s to change from carnivorous insect eaters to plan...ocial insects rapidly spread throughout coastal Ca...y native insects and creating ant infestations fam...the University of California, San Diego and the Un...rtunistic, changing dietary preferences of Califor...
...emain through reporting of 2007 fiscal year, BEDF... leading supplier of broadband technology and biom...g will resume the position of Chief,Financial Offi...viously,Aware,s CFO from June 1996 until September...e departing in February after,Aware has completed ...
Other Biology News:A research of the UGR shows the genetic predisposition to develop alcohol abuse 2Study links success of invasive Argentine ants to diet shifts 2Study links success of invasive Argentine ants to diet shifts 3Aware, Inc. Announces Richard Moberg to Return as CFO 2Aware, Inc. Announces Richard Moberg to Return as CFO 3
(Date:11/8/2009)...obal temperatures and energy costs continue to soa...stainable future. An attractive replacement for ...online in Genome Research ( www.genome.org ), sc...oethanol-producing microorganisms, uncovering gene...technologies needed to implement production on a g...
(Date:11/6/2009)...v. 6 Helix BioPharma Cor...nounced that John Docherty, president and chief op...ord,s 6th annual Investor Summit on November 10, 2...ty. Mr. Docherty will provide an overview of the ...OS47 and Topical Interferon Alpha-2b. The slide s...
(Date:11/6/2009)...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... today announced updated results from a Phase II s...arcomas metastatic to the lung in a poster present...y Society Meeting held in Miami Beach, Florida, fr...ntitled "A Phase II Study of Intravenous REOLYSIN ...
(Date:11/5/2009)...Nov. 5 The endangered black-footed...U.S. This rare carnivore feeds on prairie dogs. ...nd often entire population die-offs in towns occur...implemented a ferret breeding program and has been...merly native habitat. Unfortunately, plague can s...
Breaking Biology Technology:Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
...rgies to Raising Awareness and Funds to, Advance ... Neurological, Other Serious Me...The Focused Ultrasound,Surgery Foundation, founded...n of a breakthrough therapeutic technology -- Magn...- is pleased to announce that author,John Grisham ...
...August 13, 2008 at 9:00 a.m. ET --, BEIJING, Aug....mex:,SVA), a leading developer and provider of vac...ncial results for the six and three-month,periods ... -- Sales increased 73% year-over-year to $16.5 mi...p 55%, and 180,000 doses of Bilive(R) based on...
...t 2:00 p.m. CET, AMSTERDAM, August 13 Amsterdam ...n the field of human gene therapy,today reported i...hlights, - Positive results of pivotal trial for ...e I - European patent for treatment of Non-Alcoho...of Duchenne Muscular Dystrophy from La Sapienza U...
Other Biology Technology:John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technology's Potential to Help 'Millions of Patients' 2John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technology's Potential to Help 'Millions of Patients' 3Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 2Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 3Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 4Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 5Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 6Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 7Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 8Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 9Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 10Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results 11Amsterdam Molecular Therapeutics Reports Half Year Results 2008 2Amsterdam Molecular Therapeutics Reports Half Year Results 2008 3Amsterdam Molecular Therapeutics Reports Half Year Results 2008 4
Mycoplasma Testing from AbD Serotec
...Exonuclease-free Klenow Fragment is a genetically ...xonuclease activity has been removed, leaving only...f exonuclease activity makes Exo- Klenow Fragment ...ng of DNA probes by the random primed method, and ...
T4 RNA Ligase from Roche Applied Science
T7 RNA Polymerase from Roche Applied Science
Biology Products: